Current Report Filing (8-k)
August 02 2016 - 1:23PM
Edgar (US Regulatory)
U.S. SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities and Exchange Act of 1934
Date of Report (Date of earliest event reported): July 27, 2016
GREAT CHINA INTERNATIONAL HOLDINGS, INC.
(Exact name of registrant as specified in its charter)
0-23015
(Commission File No.)
Nevada
(State or other jurisdiction of
incorporation or organization)
|
87-0450232
(IRS Employer Identification No.)
|
C Site 25-26F President Building, No. 69 Heping North Street
Heping District, Shenyang 110003, Peoples Republic of China
(Address of principal executive offices)
0086-24-22813888
(Registrant’s telephone number)
Not applicable
(Former Name or Former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (
see
General Instruction A.2. below):
[ ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
[ ]
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
[ ]
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Item 5.07 Submission of Matters to a Vote of Security Holders
On July 27, 2016, the stockholders of Great China International Holdings, Inc. (“Great China or the “Company”) approved by majority written consent the following amendment to the Articles of Incorporation for the Company:
RESOLVED, that the following amendment to the Articles of Incorporation of the Corporation is hereby adopted and approved:
The Articles of Incorporation of the Corporation are hereby amended by deleting Article I in its entirety and inserting the following in lieu thereof:
ARTICLE I
NAME
The name of the Corporation is: HH Biotechnology Holdings Company
We expect to file a certificate of amendment with the state of Nevada to effectuate the name change within a few days after the later of the date that is 20 days from the date this Information Statement is disseminated to our stockholders and the date the Financial Industry Regulatory Authority completes its review and processing of our name change.
SIGNATURES
Pursuant to the requirements of the Securities and Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
Great China International Holdings, Inc.
|
|
|
|
|
|
|
|
|
|
Date: August 2, 2016
|
By:
|
/s/ Frank Jiang
|
|
|
|
Frank Jiang, Chief Executive Officer
|
|
HH Biotechnology (CE) (USOTC:HHBT)
Historical Stock Chart
From Nov 2024 to Dec 2024
HH Biotechnology (CE) (USOTC:HHBT)
Historical Stock Chart
From Dec 2023 to Dec 2024